---
title: ProBio vs Minaris Advanced Therapies
slug_a: probio
slug_b: wuxi-advanced-therapies
site: cdmo
review_signal_gate: closed
canonical_path: /compare/probio/wuxi-advanced-therapies
---

# ProBio vs Minaris Advanced Therapies

Side-by-side profile data from each company listing on this directory.

## ProBio

- Profile: [/companies/probio](/companies/probio)

ProBio — ProBio is a leading global CDMO subsidiary of GenScript Biotech Corporation, providing end-to-end services for biologics and cell & gene therapy (CGT) from drug discovery through commercialization.

Services: 7. Modalities: 7. Indications: 1. Locations: 6. Certifications: 3. The strongest documented coverage currently appears in services (7).

### Services

- Protein Engineering
- In Vitro Pharmacology
- Bioanalysis
- Immunogenicity Assays (ADA / NAb)
- Flow Cytometry Services
- Analytical Method Development & Validation
- ICH Stability Studies

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- mRNA
- Cell Therapy
- Gene Therapy
- Vaccine
- AAV / Viral Vector Platform

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Data not yet provided.

## Minaris Advanced Therapies

- Profile: [/companies/wuxi-advanced-therapies](/companies/wuxi-advanced-therapies)

Minaris Advanced Therapies — Pure-play cell and gene therapy CDMO with over 25 years of GMP manufacturing, process development, and biosafety testing expertise. Serves advanced therapy innovators globally from early stage through commercialization.

Services: 15. Modalities: 6. Indications: 0. Locations: 14. Certifications: 6. The strongest documented coverage currently appears in services (15).

### Services

- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- Viral Vector Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- Vaccine Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- Vaccine
- AAV / Viral Vector Platform

### Development capabilities

- Analytical method development
- ICH stability testing
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Viral Vector